Common use of HIV Prevention Services Clause in Contracts

HIV Prevention Services. LPHA’s HIV Prevention Program must include the following minimum components: (1) Identify persons with HIV infection or uninfected persons at risk for HIV infection as follows: (a) Provide rapid HIV testing for individuals at risk, including those individuals who request HIV Screening, in clinical and non-clinical settings following guidance outlined in “Centers for Disease Control and Prevention Implementing HIV Testing in Nonclinical Settings: A Guide for HIV Testing Providers” which can be found at: xxxxx://xxx.xxx.xxx/hiv/pdf/testing/CDC_HIV_Implementing_HIV_Testing_in_ Nonclinical_Settings.pdf (b) Provide HIV testing (either rapid or conventional) for individuals presenting with a bacterial STI, particularly, rectal gonorrhea and/or syphilis. For those individuals presenting for HIV testing, offer other Sexually Transmitted Infection (STI) testing. (c) Offer confirmatory testing via a laboratory or by a second rapid HIV test from a different manufacturer than the first rapid HIV test for individuals with positive rapid HIV test results. (d) Provide referral for medical and supportive services and ensure linkage to these services for individuals who are HIV positive. (e) Use an OHA approved HIV Test Request Form for each testing event funded in whole, or part, by the HIV Prevention Program. The form can be found at: xxxxx://xxx.xxxxxx.xxx/oha/PH/DISEASESCONDITIONS/HIVSTDVIRALHEP ATITIS/HIVPREVENTION/Documents/hivtestprocess/HIVPreventionTestForm _HPP.pdf (f) Use a Confidential HIV Test for complete data collection. No HIV test funded in whole, or part, by the HIV Prevention Program, can be an Anonymous HIV Test (with the exception of an At-Home HIV Test as provided in (g) below). (g) With prior approval from OHA, provide At-Home HIV Test kits to persons at risk for HIV infection whose status is unknown. (h) Have a Certificate of Waiver from the Clinical Laboratory Improvement Amendments (CLIA) program if offering a rapid HIV test. (i) Ensure that all staff who provide rapid HIV tests are trained and certified to do so as defined by the product-specific guidelines identified by the manufacturer of the rapid HIV test in use. Staff are also required to complete an OHA-approved online training around provision of HIV testing and prevention services. (2) Provide comprehensive HIV-related prevention services for person living with diagnosed HIV infection as follows: (a) Provide Partner Services for those with newly diagnosed HIV infection and those previously diagnosed with HIV infection, and their partners. (b) Provide linkage to medical care, treatment, and prevention services for PLWH. (c) Link persons with newly diagnosed HIV infection to medical care within 30 days of diagnosis. (d) Re-engage PLWH who are currently not in care into medical care. (e) Support retention in medical care, treatment, and prevention services for PLWH. (f) Follow up with HIV-positive individuals identified as being out of care by HIV surveillance in order to determine current residence and link to HIV medical care and other supportive services as needed (i.e. Data to Care activities). (g) Work in conjunction with OHA staff to respond to and intervene in HIV transmission clusters and HIV Outbreaks as necessary. (3) Provide comprehensive HIV-related prevention services for HIV-negative persons at risk for HIV infection as follows: (a) Increase awareness of and expand access to PrEP, including medication adherence. (b) Promote consumer knowledge, access, and use of PrEP, including referrals into or the provision of PrEP navigation services. (c) Identify community/individual candidates for PrEP services using HIV surveillance, testing, and other data (refer to US Public Health Service Preexposure Prophylaxis for the Prevention of HIV Infection in the United States (4) Conduct community-level HIV prevention activities as follows: (a) Distribute condoms to populations engaging in high risk behaviors and provide referrals to the free mail-order condom service funded by OHA (xxxxx://xxx.xxxxxxxxxx.xxx/pages/oregon). (b) Distribute and have available culturally and language appropriate HIV information for community members in the local jurisdiction; this may include, but not be limited to, written materials, social media, public information, and meeting presentations. For this process use a CDC defined Program Review Panel which is described in the document available at: xxxxx://xxx.xxx.xxx/hiv/pdf/funding/announcements/ps12-1201/cdc-hiv-ps12- 1201-content-review-guidance.pdf (c) Support and promote the use of media technology (e.g. internet, texting, web applications) for HIV prevention messaging to targeted populations and communities. (d) Encourage community mobilization to create enabling environments that support HIV prevention by actively involving community members in efforts to raise HIV awareness, building support for and involvement in HIV prevention efforts, motivating individuals to work to end HIV stigma and encouraging HIV risk reduction. (e) Create a specific engagement plan for communities of color which includes anti- stigma approaches and activities for populations which are in alignment with the Epidemiologic Overview in the “Oregon Integrated HIV Prevention and Care Plan, 2017-2021.” (f) Administer harm reduction efforts, if permitted and based on local need, to reduce the risk of transmission of HIV/Hepatitis C, such as, but not limited to, operation of a Syringe Service Program, the purchase and distribution of wound care supplies, sharps containers, and clean supplies used for injection drug use; however, purchase of syringes (needles), cookers and naloxone is not allowable with these funds. (xxxxx://xxx.xxx.xxx/hiv/risk/ssps.html)

HIV Prevention Services. LPHA’s HIV Prevention Program must include the following minimum components: (1) Identify persons with HIV infection or uninfected persons at risk for HIV infection as follows: (a) Provide rapid HIV testing for individuals at risk, including those individuals who request HIV Screening, in clinical and non-clinical settings following guidance outlined in “Centers for Disease Control and Prevention Implementing HIV Testing in Nonclinical Settings: A Guide for HIV Testing Providers” which can be found at: xxxxx://xxx.xxx.xxx/hiv/pdf/testing/CDC_HIV_Implementing_HIV_Testing_in_ Nonclinical_Settings.pdf (b) Provide HIV testing (either rapid or conventional) for individuals presenting with a bacterial STI, particularly, rectal gonorrhea and/or syphilis. For those individuals presenting for HIV testing, offer other Sexually Transmitted Infection (STI) testing. (c) Offer confirmatory testing via a laboratory or by a second rapid HIV test from a different manufacturer than the first rapid HIV test for individuals with positive rapid HIV test results. (d) Provide referral for medical and supportive services and ensure linkage to these services for individuals who are HIV positive. (e) Use an OHA approved HIV Test Request Form for each testing event funded in whole, or part, by the HIV Prevention Program. The form can be found at: xxxxx://xxx.xxxxxx.xxx/oha/PH/DISEASESCONDITIONS/HIVSTDVIRALHEP ATITIS/HIVPREVENTION/Documents/hivtestprocess/HIVPreventionTestForm _HPP.pdfHIVPreventionTestForm (f) Use a Confidential HIV Test for complete data collection. No HIV test funded in whole, or part, by the HIV Prevention Program, can be an Anonymous HIV Test (with the exception of an At-Home HIV Test as provided in (g) below). (g) With prior approval from OHA, provide At-Home HIV Test kits to persons at risk for HIV infection whose status is unknown. (h) Have a Certificate of Waiver from the Clinical Laboratory Improvement Amendments (CLIA) program if offering a rapid HIV test. (i) Ensure that all staff who provide rapid HIV tests are trained and certified to do so as defined by the product-specific guidelines identified by the manufacturer of the rapid HIV test in use. Staff are also required to complete an OHA-approved online training around provision of HIV testing and prevention services. (2) Provide comprehensive HIV-related prevention services for person living with diagnosed HIV infection as follows: (a) Provide Partner Services for those with newly diagnosed HIV infection and those previously diagnosed with HIV infection, and their partners. (b) Provide linkage to medical care, treatment, and prevention services for PLWH. (c) Link persons with newly diagnosed HIV infection to medical care within 30 days of diagnosis. (d) Re-engage PLWH who are currently not in care into medical care. (e) Support retention in medical care, treatment, and prevention services for PLWH. (f) Follow up with HIV-positive individuals identified as being out of care by HIV surveillance in order to determine current residence and link to HIV medical care and other supportive services as needed (i.e. Data to Care activities). (g) Work in conjunction with OHA staff to respond to and intervene in HIV transmission clusters and HIV Outbreaks as necessary. (3) Provide comprehensive HIV-related prevention services for HIV-negative persons at risk for HIV infection as follows: (a) Increase awareness of and expand access to PrEP, including medication adherence. (b) Promote consumer knowledge, access, and use of PrEP, including referrals into or the provision of PrEP navigation services. (c) Identify community/individual candidates for PrEP services using HIV surveillance, testing, and other data (refer to US Public Health Service Preexposure Prophylaxis for the Prevention of HIV Infection in the United States (4) Conduct community-level HIV prevention activities as follows: (a) Distribute condoms to populations engaging in high high-risk behaviors and provide referrals to the free mail-order condom service funded by OHA (xxxxx://xxx.xxxxxxxxxx.xxx/pages/oregon). (b) Distribute and have available culturally and language appropriate HIV information for community members in the local jurisdiction; this may include, but not be limited to, written materials, social media, public information, and meeting presentations. For this process use a CDC defined Program Review Panel which is described in the document available at: xxxxx://xxx.xxx.xxx/hiv/pdf/funding/announcements/ps12-1201/cdc-hiv-ps12- 1201-content-review-guidance.pdf (c) Support and promote the use of media technology (e.g. internet, texting, web applications) for HIV prevention messaging to targeted populations and communities. (d) Encourage community mobilization to create enabling environments that support HIV prevention by actively involving community members in efforts to raise HIV awareness, building support for and involvement in HIV prevention efforts, motivating individuals to work to end HIV stigma and encouraging HIV risk reduction. (e) Create a specific engagement plan for communities of color which includes anti- stigma approaches and activities for populations which are in alignment with the Epidemiologic Overview in the “Oregon Integrated HIV Prevention and Care Plan, 2017-2021.” (f) Administer harm reduction efforts, if permitted and based on local need, to reduce the risk of transmission of HIV/Hepatitis C, such as, but not limited to, operation of a Syringe Service Program, the purchase and distribution of wound care supplies, sharps containers, and clean supplies used for injection drug use; however, purchase of syringes (needles), cookers and naloxone is not allowable with these funds. (xxxxx://xxx.xxx.xxx/hiv/risk/ssps.html)

HIV Prevention Services. LPHA’s HIV Prevention Program must include the following minimum components: (1) Identify persons with HIV infection or uninfected persons at risk for HIV infection as follows: (a) Provide rapid HIV testing for individuals at risk, including those individuals who request HIV Screening, for HIV in clinical and non-clinical settings following guidance outlined in “Centers for Disease Control and Prevention Implementing HIV Testing in Nonclinical Settings: A Guide for HIV Testing Providers” which can be found at: xxxxx://xxx.xxx.xxx/hiv/pdf/testing/CDC_HIV_Implementing_HIV_Testing_in_ Nonclinical_Settings.pdf (b) Provide HIV testing (either rapid or conventional) for individuals presenting with a bacterial STI, particularly, rectal gonorrhea and/or syphilis. For those individuals presenting for HIV testing, offer other Sexually Transmitted Infection (STI) testing. (c) Offer confirmatory testing via a laboratory or by a second rapid HIV test from a different manufacturer than the first rapid HIV test for individuals with positive rapid HIV test results. (d) Provide referral for medical and supportive services and ensure linkage to these services for individuals who are HIV positive. (e) Use an OHA approved HIV Test Request Form which is available from the Oregon State Public Health Laboratory for each testing event funded in whole, or part, by the HIV Prevention Program. The form can be found at: xxxxx://xxx.xxxxxx.xxx/oha/PH/DISEASESCONDITIONS/HIVSTDVIRALHEP ATITIS/HIVPREVENTION/Documents/hivtestprocess/HIVPreventionTestForm _HPP.pdf. (f) Use a Confidential HIV Test Testing for complete data collection. No , no HIV test funded in whole, or part, by the HIV Prevention Program, can be an Anonymous HIV Test (with the exception of an At-Home HIV Test as provided in (g) below)Test. (g) With prior approval from OHA, provide At-Home HIV Test kits to persons at risk for HIV infection whose status is unknown. (h) Have a Certificate of Waiver from the Clinical Laboratory Improvement Amendments (CLIA) program if offering a rapid HIV test. (ih) Ensure that all staff who provide rapid HIV tests are trained and certified to do so as defined by the product-specific guidelines identified by the manufacturer of the rapid HIV test in use. Staff are also required to complete an OHA-approved online training around provision of HIV testing and prevention services. (2) Provide comprehensive HIV-related prevention services for person living with diagnosed HIV infection as follows: (a) Provide Partner Services for those with newly diagnosed HIV infection and those previously diagnosed with HIV infection, and their partners. (b) Provide linkage to medical care, treatment, and prevention services for PLWH. (c) Link persons with newly diagnosed HIV infection to medical care within 30 days of diagnosis. (d) Re-engage PLWH who are currently not in care into medical care. (e) Support retention in medical care, treatment, and prevention services for PLWH. (f) Follow up with HIV-positive individuals identified as being out of care by HIV surveillance in order to determine current residence and link to HIV medical care and other supportive services as needed (i.e. Data to Care activities). (g) Work in conjunction with OHA staff to respond to and intervene in HIV transmission clusters and HIV Outbreaks as necessary. (3) Provide comprehensive HIV-related prevention services for HIV-negative persons at risk for HIV infection as follows: (a) Increase awareness of and expand access to PrEP, PrEP including medication adherence. (b) Promote consumer knowledge, access, and use of PrEP, PrEP including referrals into or the provision of PrEP navigation services. (c) Identify community/individual candidates for PrEP services using HIV surveillance, testing, and other data (refer to US Public Health Service Preexposure Prophylaxis for the Prevention of HIV Infection in the United StatesStates – 2014 Clinical Practice Guidelines: xxxxx://xxx.xxx.xxx/hiv/pdf/guidelines/PrEPguidelines2014.pdf) (4) Conduct community-level HIV prevention activities as follows: (a) Distribute condoms to populations engaging in high risk behaviors and provide referrals to the free mail-order condom service funded by OHA (xxxxx://xxx.xxxxxxxxxx.xxx/pages/oregon)behaviors. (b) Distribute and have available culturally and language appropriate HIV information for community members in the local jurisdiction; this may include, but not be limited to, written materials, social media, public information, and meeting presentations. For this process use a CDC defined Program Review Panel which is described in the document available at: xxxxx://xxx.xxx.xxx/hiv/pdf/funding/announcements/ps12-1201/cdc-hiv-ps12- 1201-content-review-guidance.pdf (c) Support and promote the use of media technology (e.g. internet, texting, web applications) for HIV prevention messaging to targeted populations and communities. (d) Encourage community mobilization to create enabling environments that support HIV prevention by actively involving community members in efforts to raise HIV awareness, building support for and involvement in HIV prevention efforts, motivating individuals to work to end HIV stigma and encouraging HIV risk reduction. (e) Create a specific engagement plan for communities of color which includes anti- stigma approaches and activities for populations which are in alignment with the Epidemiologic Overview in the “Oregon Integrated HIV Prevention and Care Plan, 2017-2021.” (f) Administer harm reduction efforts, if permitted and based on local need, to reduce the risk of transmission of HIV/Hepatitis C, such as, but not limited to, operation of a Syringe Service Program, the purchase and distribution of wound care supplies, sharps containers, and clean supplies used for injection drug use; however, however purchase of syringes (needles), cookers ) and naloxone is not allowable with these funds. (xxxxx://xxx.xxx.xxx/hiv/risk/ssps.html)

HIV Prevention Services. LPHA’s HIV Prevention Program must include the following minimum components: (1) Identify persons with HIV infection or uninfected persons at risk for HIV infection as follows: (a) Provide rapid HIV testing for individuals at risk, including those individuals who request HIV Screening, in clinical and non-clinical settings following guidance outlined in “Centers for Disease Control and Prevention Implementing HIV Testing in Nonclinical Settings: A Guide for HIV Testing Providers” which can be found at: xxxxx://xxx.xxx.xxx/hiv/pdf/testing/CDC_HIV_Implementing_HIV_Testing_in_ Nonclinical_Settings.pdf (b) Provide HIV testing (either rapid or conventional) for individuals presenting with a bacterial STI, particularly, rectal gonorrhea and/or syphilis. For those individuals presenting for HIV testing, offer other Sexually Transmitted Infection (STI) testing. (c) Offer confirmatory testing via a laboratory or by a second rapid HIV test from a different manufacturer than the first rapid HIV test for individuals with positive rapid HIV test results. (d) Provide referral for medical and supportive services and ensure linkage to these services for individuals who are HIV positive. (e) Use an OHA approved HIV Test Request Form for each testing event funded in whole, or part, by the HIV Prevention Program. The form can be found at: xxxxx://xxx.xxxxxx.xxx/oha/PH/DISEASESCONDITIONS/HIVSTDVIRALHEP ATITIS/HIVPREVENTION/Documents/hivtestprocess/HIVPreventionTestForm _HPP.pdfHIVPreventionTestForm (f) Use a Confidential HIV Test for complete data collection. No HIV test funded in whole, or part, by the HIV Prevention Program, can be an Anonymous HIV Test (with the exception of an At-Home HIV Test as provided in (g) below). (g) With prior approval from OHA, provide At-Home HIV Test kits to persons at risk for HIV infection whose status is unknown. (h) Have a Certificate of Waiver from the Clinical Laboratory Improvement Amendments (CLIA) program if offering a rapid HIV test. (i) Ensure that all staff who provide rapid HIV tests are trained and certified to do so as defined by the product-specific guidelines identified by the manufacturer of the rapid HIV test in use. Staff are also required to complete an OHA-approved online training around provision of HIV testing and prevention services. (2) Provide comprehensive HIV-related prevention services for person living with diagnosed HIV infection as follows: (a) Provide Partner Services for those with newly diagnosed HIV infection and those previously diagnosed with HIV infection, and their partners. (b) Provide linkage to medical care, treatment, and prevention services for PLWH. (c) Link persons with newly diagnosed HIV infection to medical care within 30 days of diagnosis. (d) Re-engage PLWH who are currently not in care into medical care. (e) Support retention in medical care, treatment, and prevention services for PLWH. (f) Follow up with HIV-positive individuals identified as being out of care by HIV surveillance in order to determine current residence and link to HIV medical care and other supportive services as needed (i.e. Data to Care activities). (g) Work in conjunction with OHA staff to respond to and intervene in HIV transmission clusters and HIV Outbreaks as necessary. (3) Provide comprehensive HIV-related prevention services for HIV-negative persons at risk for HIV infection as follows: (a) Increase awareness of and expand access to PrEP, including medication adherence. (b) Promote consumer knowledge, access, and use of PrEP, including referrals into or the provision of PrEP navigation services. (c) Identify community/individual candidates for PrEP services using HIV surveillance, testing, and other data (refer to US Public Health Service Preexposure Prophylaxis for the Prevention of HIV Infection in the United States (4) Conduct community-level HIV prevention activities as follows: (a) Distribute condoms to populations engaging in high risk behaviors and provide referrals to the free mail-order condom service funded by OHA (xxxxx://xxx.xxxxxxxxxx.xxx/pages/oregon). (b) Distribute and have available culturally and language appropriate HIV information for community members in the local jurisdiction; this may include, but not be limited to, written materials, social media, public information, and meeting presentations. For this process use a CDC defined Program Review Panel which is described in the document available at: xxxxx://xxx.xxx.xxx/hiv/pdf/funding/announcements/ps12-1201/cdc-hiv-ps12- 1201-content-review-guidance.pdf (c) Support and promote the use of media technology (e.g. internet, texting, web applications) for HIV prevention messaging to targeted populations and communities. (d) Encourage community mobilization to create enabling environments that support HIV prevention by actively involving community members in efforts to raise HIV awareness, building support for and involvement in HIV prevention efforts, motivating individuals to work to end HIV stigma and encouraging HIV risk reduction. (e) Create a specific engagement plan for communities of color which includes anti- stigma approaches and activities for populations which are in alignment with the Epidemiologic Overview in the “Oregon Integrated HIV Prevention and Care Plan, 2017-2021.” (f) Administer harm reduction efforts, if permitted and based on local need, to reduce the risk of transmission of HIV/Hepatitis C, such as, but not limited to, operation of a Syringe Service Program, the purchase and distribution of wound care supplies, sharps containers, and clean supplies used for injection drug use; however, purchase of syringes (needles), cookers and naloxone is not allowable with these funds. (xxxxx://xxx.xxx.xxx/hiv/risk/ssps.html)